LOGIN  |  REGISTER
Terns Pharmaceuticals
Chimerix

Evolent Health to Participate in Upcoming Conferences

March 03, 2023 | Last Trade: US$9.23 0.06 -0.65

WASHINGTON, March 3, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Financial Officer John Johnson and Vice President, Investor Relations, Seth Frank will participate in upcoming investor conferences, including meetings with institutional investors and presentations.

A live audio-only webcast and replay for these events will be available on the investor relations section of Evolent's website at ir.evolenthealth.com/, unless otherwise noted below.

  • Messrs. Johnson and Frank will present at the Cowen 43rd Annual Healthcare Conference at The Boston Marriott Copley Place Hotel, Boston, on Tuesday, March 7, 2023, at 10:30 a.m. ET.
  • Mr. Frank will present at the Annual Jefferies Value-Based Healthcare Summit at The W South Beach, Miami Beach, Fla., on Monday, March 13, 2023. No webcast will be available for this event.
  • Messrs. Johnson and Frank will present at the Annual Barclays Global Healthcare Conference at The Lowes Hotel, Miami Beach, Fla., on Tuesday, March 14, 2023, at 3:35 p.m. ET.

About Evolent Health 

Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Our solutions encompass total cost of care management, specialty care management and administrative simplification. Evolent serves a national base of leading payers and providers, is the first company to receive the National Committee for Quality Assurance's Population Health Program Accreditation and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolenthealth.com.

Contacts:
Seth R. Frank
Vice President, Investor Relations
Evolent Health, Inc.
This email address is being protected from spambots. You need JavaScript enabled to view it.
571-895-3919 (W)

Stock Quote

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page